Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children (Q40947727)

25 September 2017

title

Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children (English)

1 reference

pneumococcal conjugate vaccine

25 September 2017

main subject

1 reference

based on heuristic

inferred from title

invasive disease potential

1 reference

Emmanuelle Varon

1

1 reference

25 September 2017

Robert Cohen

2

1 reference

25 September 2017

Stéphane Béchet

3

1 reference

25 September 2017

Catherine Doit

4

1 reference

25 September 2017

Corinne Levy

5

1 reference

25 September 2017

language of work or name

English

0 references

publication date

14 October 2015

1 reference

25 September 2017

1 reference

25 September 2017

volume

33

1 reference

25 September 2017

issue

46

1 reference

25 September 2017

page(s)

6178-6185

1 reference

Streptococcus pneumoniae colonisation: the key to pneumococcal disease

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

The fundamental link between pneumococcal carriage and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Temporal and Geographic Stability of the Serogroup‐Specific Invasive Disease Potential of Streptococcus pneumoniae in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

[Annual trends (2008-2011) in early childhood vaccination coverage for the French population: the Vaccinoscopie(®) study].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Clonal expansion of the macrolide resistant ST386 within pneumococcal serotype 6C in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Clonal Relationships between Invasive and Carriage Streptococcus pneumoniae and Serotype‐ and Clone‐Specific Differences in Invasive Disease Potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Population structure of hyperinvasive serotype 12F, clonal complex 218 Streptococcus pneumoniae revealed by multilocus boxB sequence typing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Outbreak of invasive Streptococcus pneumoniae serotype 12F among a marginalized inner-city population in Winnipeg, Canada, 2009-2011.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

Blood cultures in the emergency department evaluation of childhood pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.10.015

10.1016/J.VACCINE.2015.10.015

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference